NO180772C - Terbinafinpreparater for topisk påföring - Google Patents

Terbinafinpreparater for topisk påföring

Info

Publication number
NO180772C
NO180772C NO921958A NO921958A NO180772C NO 180772 C NO180772 C NO 180772C NO 921958 A NO921958 A NO 921958A NO 921958 A NO921958 A NO 921958A NO 180772 C NO180772 C NO 180772C
Authority
NO
Norway
Prior art keywords
terbinafine
preparations
topical application
topical
application
Prior art date
Application number
NO921958A
Other languages
English (en)
Norwegian (no)
Other versions
NO180772B (no
NO921958D0 (no
NO921958L (no
Inventor
Friedrich Richter
Michel Steiger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO180772(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919110884A external-priority patent/GB9110884D0/en
Priority claimed from GB919111477A external-priority patent/GB9111477D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO921958D0 publication Critical patent/NO921958D0/no
Publication of NO921958L publication Critical patent/NO921958L/no
Publication of NO180772B publication Critical patent/NO180772B/no
Publication of NO180772C publication Critical patent/NO180772C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
NO921958A 1991-05-20 1992-05-18 Terbinafinpreparater for topisk påföring NO180772C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110884A GB9110884D0 (en) 1991-05-20 1991-05-20 Pharmaceutical compositions
GB919111477A GB9111477D0 (en) 1991-05-29 1991-05-29 Pharmaceutical composition

Publications (4)

Publication Number Publication Date
NO921958D0 NO921958D0 (no) 1992-05-18
NO921958L NO921958L (no) 1992-11-23
NO180772B NO180772B (no) 1997-03-10
NO180772C true NO180772C (no) 1997-06-18

Family

ID=26298929

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921958A NO180772C (no) 1991-05-20 1992-05-18 Terbinafinpreparater for topisk påföring

Country Status (29)

Country Link
US (2) US5681849A (it)
EP (1) EP0515310B1 (it)
JP (1) JP2651311B2 (it)
KR (1) KR100303095B1 (it)
AT (1) AT400517B (it)
AU (1) AU647922B2 (it)
CA (1) CA2068957C (it)
CH (1) CH683823A5 (it)
CY (1) CY1942A (it)
CZ (2) CZ283019B6 (it)
DE (1) DE4215450B4 (it)
DK (1) DK0515310T3 (it)
ES (1) ES2186668T3 (it)
FI (2) FI102458B1 (it)
FR (1) FR2676646B1 (it)
GB (1) GB2255908B (it)
HK (1) HK148896A (it)
HU (1) HU223343B1 (it)
IE (1) IE70913B1 (it)
IL (1) IL101903A (it)
IT (1) IT1260710B (it)
LU (1) LU88114A1 (it)
MX (1) MX9202328A (it)
NO (1) NO180772C (it)
PT (1) PT515310E (it)
RO (1) RO111986B1 (it)
SA (1) SA92130087B1 (it)
SK (1) SK281615B6 (it)
UA (1) UA39853C2 (it)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
WO2000024377A1 (en) * 1998-10-23 2000-05-04 Idea Innovative Dermale Applikationen Gmbh Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
SI1031347T1 (en) 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
GB0003932D0 (en) 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR100389671B1 (ko) * 2000-11-24 2003-06-27 한미약품 주식회사 염산 테르비나핀을 함유하는 항진균제 외용 약제 조성물
US6490390B1 (en) * 2001-01-05 2002-12-03 Phaethon Communications Grating writing systems based on an acousto-optic element
GB0103046D0 (en) * 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
KR100423666B1 (ko) 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
BRPI0101486B1 (pt) * 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20070190019A1 (en) * 2003-06-23 2007-08-16 Chunfeng Guo Compositions and methods for topical administration
WO2005002561A1 (ja) * 2003-07-03 2005-01-13 Taisho Pharmaceutical Co.,Ltd. 外用抗真菌剤組成物
KR100581169B1 (ko) * 2003-07-07 2006-05-17 한국유나이티드제약 주식회사 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법
JP2005104916A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 抗真菌組成物
AU2004296784B2 (en) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
JP2008504359A (ja) * 2004-07-02 2008-02-14 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 病理的感染症を治療するための組成物及び方法
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
US20090118721A1 (en) * 2005-07-21 2009-05-07 Eric Bornstein Near Infrared Microbial Elimination Laser System (NIMELS)
US7359057B2 (en) * 2005-08-26 2008-04-15 Ball Aerospace & Technologies Corp. Method and apparatus for measuring small shifts in optical wavelengths
NZ566401A (en) 2005-09-29 2011-03-31 Novartis Ag Topical antifungal compositions of terbinafine with hydroxypropylcellulose and an octylacrylamide acrylate copolymer
US20080167312A1 (en) * 2006-12-08 2008-07-10 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
WO2008102349A2 (en) * 2007-02-21 2008-08-28 Power Paper Ltd Terbinafine formulation for iontophoresis
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
US20080261986A1 (en) * 2007-03-30 2008-10-23 Friden Phillip M Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
EP2340043A4 (en) * 2008-10-31 2012-09-19 Moberg Derma Ab TOPICAL COMPOSITION COMPRISING A COMBINATION OF AT LEAST TWO PENETRATION AGENTS
ES2598753T3 (es) 2012-11-27 2017-01-30 Eduardo Cos Alfonso Composición farmacéutica para el tratamiento de la tendinitis calcificada y/o bursitis calcificada
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US20170266106A1 (en) 2014-12-01 2017-09-21 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
US20180369174A1 (en) * 2015-12-16 2018-12-27 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
TWI656883B (zh) * 2017-08-21 2019-04-21 高雄醫學大學 光敏劑或其前驅藥物的醫藥載體

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0024587B1 (en) * 1979-08-22 1984-11-14 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
JPS6058914A (ja) * 1983-09-12 1985-04-05 Shionogi & Co Ltd イミダゾ−ル系抗真菌性外用ゲル製剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
JP2633555B2 (ja) * 1987-03-23 1997-07-23 株式会社東芝 半導体装置の製造方法
ES2038344T3 (es) * 1988-01-13 1993-07-16 Schwarz Pharma Ag Soluciones concentradas de corticoesteroides y metodo para su fabricacion.
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
HUT58201A (en) * 1989-03-03 1992-02-28 Sandoz Ag Process for producing antiphlogistic pharmaceutical composition containing naphtalene-methan-amino derivatives
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására

Also Published As

Publication number Publication date
HK148896A (en) 1996-08-16
CS149192A3 (en) 1992-12-16
CY1942A (en) 1997-05-16
ITRM920361A0 (it) 1992-05-12
UA39853C2 (uk) 2001-07-16
GB9210579D0 (en) 1992-07-01
FI981777A0 (fi) 1998-08-18
RO111986B1 (ro) 1997-04-30
KR100303095B1 (ko) 2001-11-22
JP2651311B2 (ja) 1997-09-10
FR2676646A1 (fr) 1992-11-27
DE4215450A1 (de) 1992-11-26
AU1631792A (en) 1992-11-26
PT515310E (pt) 2003-03-31
CA2068957C (en) 2002-12-17
IL101903A0 (en) 1992-12-30
AT400517B (de) 1996-01-25
DE4215450B4 (de) 2006-04-27
IE70913B1 (en) 1997-01-15
AU647922B2 (en) 1994-03-31
ITRM920361A1 (it) 1993-11-12
SK281615B6 (sk) 2001-05-10
CA2068957A1 (en) 1992-11-21
NO180772B (no) 1997-03-10
CZ283019B6 (cs) 1997-12-17
FI102458B (fi) 1998-12-15
FR2676646B1 (fr) 1995-05-05
GB2255908A (en) 1992-11-25
MX9202328A (es) 1994-04-29
JPH05132419A (ja) 1993-05-28
SA92130087B1 (ar) 2006-05-23
LU88114A1 (fr) 1993-12-06
CZ285275B6 (cs) 1999-06-16
FI922252A0 (fi) 1992-05-18
FI922252A (fi) 1992-11-21
EP0515310A1 (en) 1992-11-25
ATA102392A (de) 1995-06-15
IL101903A (en) 1998-08-16
GB2255908B (en) 1995-10-04
HU9201518D0 (en) 1992-07-28
FI102458B1 (fi) 1998-12-15
ES2186668T3 (es) 2003-05-16
FI981777A (fi) 1998-08-18
HU223343B1 (hu) 2004-06-28
NO921958D0 (no) 1992-05-18
DK0515310T3 (da) 2003-03-03
CH683823A5 (de) 1994-05-31
IT1260710B (it) 1996-04-22
US5681849A (en) 1997-10-28
NO921958L (no) 1992-11-23
KR920021139A (ko) 1992-12-18
US5856355A (en) 1999-01-05
HUT62466A (en) 1993-05-28
IE921599A1 (en) 1992-12-02
EP0515310B1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
NO180772C (no) Terbinafinpreparater for topisk påföring
NO922506D0 (no) Farmasoeytiske preparat
ATE240716T1 (de) Aerosolpräparate
NO954146D0 (no) Belagte farmasöytiske preparater
DK36492D0 (da) Praeparat
DE59206108D1 (de) Pigmentzubereitungen
BR9408457A (pt) Preparação farmacêutica percutânia
DE59407063D1 (de) Deodorierende zubereitungen
DE69328575T2 (de) Dermatologische Präparate
ITRM920383A0 (it) Preparati liposomici.
DE69429514D1 (de) Antiparasitäre präparate
NO883609D0 (no) Farmasoeytiske preparater for topisk anvendelse.
DE69524720T2 (de) Dermatologische zubereitungen
IT1280428B1 (it) Composizione farmaceutica per uso topico
DK0653214T3 (da) Topisk antibakterielt præparat
DE59206829D1 (de) Farbbildner-Zubereitungen
NO930695D0 (no) Topiske preparater inneholdende syklosporin
DE59204637D1 (de) Pigmentpräparationen
NO920076L (no) Legemiddel for topisk anvendelse
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
DK75791D0 (da) Novel pharmaceutical preparations
NO920039L (no) Farmasoeytiske preparater
FI981925A0 (fi) Medetomidiinia sisältävät valmisteet transdermaalista antoa varten
DK206691D0 (da) Agrochemical preparations
BR1100150A (pt) Formulação tópica.

Legal Events

Date Code Title Description
MK1K Patent expired